| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| DENALI THERAPEUTICS | 8 | - | -10,88 % | ||
| BIOGEN | 7 | 54 | +0,13 % | ||
| AVADEL PHARMACEUTICALS | 7 | 6 | 0,00 % | ||
| DYNE THERAPEUTICS | 7 | - | +5,92 % | ||
| BIONTECH | 5 | 13 | -0,36 % | ||
| LIGAND PHARMACEUTICALS | 5 | 2 | +0,62 % | ||
| KYMERA THERAPEUTICS | 4 | 6 | +3,72 % | ||
| WAVE LIFE SCIENCES | 4 | 2 | -5,98 % | ||
| TERNS PHARMACEUTICALS | 4 | 2 | +6,01 % | ||
| VERA THERAPEUTICS | 3 | 9 | -0,67 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:42 | Mirum Pharmaceuticals stock price target raised to $100 by Leerink | - | Investing.com | ||
| 21:30 | Jefferies raises Olema Pharmaceuticals stock price target to $43 on SERD validation | 3 | Investing.com | ||
| 21:26 | Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz | 31 | Insider Monkey | ||
| 21:26 | Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage | 1 | Insider Monkey | ||
| 21:10 | AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study | 3 | FiercePharma | ||
| 19:54 | Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity | 1 | Seeking Alpha | ||
| 18:40 | Neue Spielregeln für medizinisches Cannabis: Chancen für Neural Therapeutics Partner Hanf.com, MindMed und Tilray | Small- & Micro Cap Investment | |||
| 18:26 | Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies | 12 | FierceBiotech | ||
| 17:18 | Jefferies raises Terns Pharmaceuticals stock price target to $70 on CML data | 3 | Investing.com | ||
| 16:46 | A former Roivant spinout bets on AI-designed drugs for immune conditions | 3 | BioPharma Dive | ||
| 16:36 | AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma | 7 | Seeking Alpha | ||
| 16:30 | Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals | 1 | Investing.com | ||
| 16:30 | TD Cowen raises Insmed stock price target to $269 on strong Brinsupri launch | 2 | Investing.com | ||
| 16:30 | EILMELDUNG: Biontech-Aktie im freien Fall - Anleger fliehen aus dem Wert! | Hebelschein-Spekulant | |||
| 16:18 | Neurocrine Bio. stock rating reiterated at Buy by TD Cowen | 2 | Investing.com | ||
| 16:06 | ANI Pharmaceuticals Director Sold $146K In Company Stock | 1 | Benzinga.com | ||
| 15:58 | Benchmark bestätigt Kaufempfehlung für Ligand Pharma mit Kursziel von 220 US-Dollar | - | Investing.com Deutsch | ||
| 15:54 | Benchmark reaffirms Buy rating on Ligand Pharma stock with $220 target | 1 | Investing.com | ||
| 15:26 | Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans | 3 | FierceBiotech | ||
| 15:18 | Nurix stock price target raised to $31 from $28 at H.C. Wainwright | 1 | Investing.com |